REGENXBIO Inc.RGNXNASDAQ
LOADING
|||
Switch Symbol:
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -16.31% | -4.50% | +469.79% | -4.20% | +22.88% |
| Gross Profit Growth | -28.54% | +124.34% | +1095.36% | +59.75% | -371.74% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +15.60% | +15.61% | +12.31% | +1.74% | +1.75% |
| Weighted Average Shares Diluted Growth | +15.60% | +15.61% | +12.47% | +1.74% | +1.75% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -20.60% | -18.12% | +10.57% | -11.20% | +5.10% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -18.09% | -18.81% | -21.98% | +2.05% | +1.17% |
| Book Value per Share Growth | -28.19% | -27.96% | -37.51% | -39.70% | -47.36% |
| Debt Growth | -7.32% | -8.13% | -53.19% | -51.05% | +218.98% |
| R&D Expense Growth | -6.45% | -1.88% | +4.78% | +24.05% | +3.07% |
| SG&A Expenses Growth | -15.86% | +5.09% | +11.24% | +5.45% | +4.28% |